Table 2

Affinities, expressed as KH, KL, and Ki values, of selected adenosine receptor agonists and antagonists to A3 receptors in human neutrophils

[3H]MRE 3008F20 binding ( KH, KL)RH[3H]MRE 3008F20 binding ( Ki) + GTP
nM % nM
Agonists
 CI-IB-MECA0.90  ± 0.129  ± 4
70  ± 885  ± 11
 IB-MECA1.5  ± 0.330  ± 6
110  ± 13103  ± 17
 HE-NECA12  ± 224  ± 3
680  ± 75750  ± 90
 NECA20  ± 229  ± 5
1,500  ± 3001,800  ± 220
 (R)-PIA42  ± 425  ± 5
2,600  ± 2702,300  ± 250
 (S)-PIA286  ± 3220  ± 6
22,000  ± 3,00025,000  ± 2,800
Antagonists ( Ki)
 MRE 3055F200.68  ± 0.150.53  ± 0.18
 MRE 3062F200.88  ± 0.270.93  ± 0.22
 MRE 3048F200.96  ± 0.311.2  ± 0.3
 MRE 3046F201.3  ± 0.31.5  ± 0.4
 MRE 3008F202.2  ± 0.22.0  ± 0.3
 CGS 15943105  ± 13127  ± 18
 DPCPX1,000  ± 1601,100  ± 175
 SCH 58261>10,000>10,000

Displacement of [3H]MRE 3008F20 was determined in the absence and presence of 100 μM GTP. KH and KL are the Ki values of the high- and low-affinity states for agonists, respectively. RHindicates the percentage of A3 receptors in the high-affinity state ± S.E.M.